Literature DB >> 29277239

Do psoas muscle area and volume correlate with postoperative complications in patients undergoing rectal cancer resection?

Aaron L Womer1, Justin T Brady1, Kevin Kalisz2, Nilam D Patel1, Raj M Paspulati2, Harry L Reynolds1, Timothy M Pawlik3, Scott R Steele4.   

Abstract

BACKGROUND: Increasingly, patients with multiple co-morbidities undergo surgery for rectal cancer. We aimed to evaluate if decreased psoas muscle area and volume, as measures for sarcopenia, were associated with postoperative morbidity.
METHODS: Retrospective review of patients undergoing rectal cancer resection at a tertiary medical center (2007-2015). Variables included demographics, co-morbidities, preoperative psoas muscle area and volume, and postoperative complications.
RESULTS: Among 180 patients (58% male, mean age 62.7 years), 44% experienced complications (n = 79), of which 38% (n = 30) were major complications. Malnourished patients had smaller height-adjusted total psoas area than non-malnourished patients (6.4 vs. 9.5 cm2/m2, p = 0.004). Among patients with imaging obtained within 90 days of surgery, major morbidity was associated with smaller total psoas area (6.7 vs. 10.5 cm2/m2, p = 0.04) and total psoas volume (26.7 vs. 42.2 cm3/m2, p = 0.04) compared to those with minor complications.
CONCLUSION: Preoperative cross-sectional imaging may help surgeons anticipate postoperative complications following rectal cancer surgery.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29277239     DOI: 10.1016/j.amjsurg.2017.10.052

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  6 in total

1.  MRI biomarker of muscle composition is associated with severity of pelvic organ prolapse.

Authors:  L Neshatian; J P Lam; B H Gurland; T Liang; L Becker; V R Sheth
Journal:  Tech Coloproctol       Date:  2022-06-21       Impact factor: 3.699

2.  Are computed tomography-based measures of specific abdominal muscle groups predictive of adverse outcomes in older cancer patients?

Authors:  S M L M Looijaard; A B Maier; A F Voskuilen; T Van Zanten; D E Bouman; J M Klaase; C G M Meskers
Journal:  Heliyon       Date:  2020-11-09

Review 3.  Clinical Relevance of Myopenia and Myosteatosis in Colorectal Cancer.

Authors:  Yoshinaga Okugawa; Takahito Kitajima; Akira Yamamoto; Tadanobu Shimura; Mikio Kawamura; Takumi Fujiwara; Ikuyo Mochiki; Yoshiki Okita; Masahiro Tsujiura; Takeshi Yokoe; Masaki Ohi; Yuji Toiyama
Journal:  J Clin Med       Date:  2022-05-06       Impact factor: 4.964

Review 4.  Sarcopenia in patients with colorectal cancer: A comprehensive review.

Authors:  Omar Vergara-Fernandez; Mario Trejo-Avila; Noel Salgado-Nesme
Journal:  World J Clin Cases       Date:  2020-04-06       Impact factor: 1.337

5.  The Role of CT-Quantified Body Composition on Longitudinal Health-Related Quality of Life in Colorectal Cancer Patients: The Colocare Study.

Authors:  Biljana Gigic; Johanna Nattenmüller; Martin Schneider; Yakup Kulu; Karen L Syrjala; Jürgen Böhm; Petra Schrotz-King; Hermann Brenner; Graham A Colditz; Jane C Figueiredo; William M Grady; Christopher I Li; David Shibata; Erin M Siegel; Adetunji T Toriola; Hans-Ulrich Kauczor; Alexis Ulrich; Cornelia M Ulrich
Journal:  Nutrients       Date:  2020-04-28       Impact factor: 5.717

6.  Preoperative Body Composition Combined with Tumor Metabolism Analysis by PET/CT Is Associated with Disease-Free Survival in Patients with NSCLC.

Authors:  Hongpei Tan; Mengtian Ma; Jing Huang; Yuqian Dong; Jiahao Liu; Ze Mi; Kai Zheng; Shuo Hu; Pengfei Rong
Journal:  Contrast Media Mol Imaging       Date:  2022-07-13       Impact factor: 3.009

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.